Trump’s Proposed Tariffs on Generic Pharmaceuticals
On July 21, 2026, President Trump announced on Truth Social a plan to impose tariffs on imported generic drugs beginning with a 0% tariff rate on August 1, 2026. The proposed tariff rate will then increase to 100% in August 2028 and 200% the following year. The goal is to encourage pharmaceutical companies to move production to the United States, showing the Administration’s willingness to use tariffs to shape investment in key industries.So far, the White House has not released an official proclamation or notice to implement this policy, which leaves some doubt about whether the tariffs will go into effect. Still, the impact on U.S. consumers and businesses could be major. About 91% of all prescriptions in the U.S. are for generic drugs, and many of these are produced abroad.
